NCT05825482 Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout® Status RECRUITING Phase NA
NCT05824325 Different Targeted Antibody-drug Conjugates For HER2 Ultra-low or No Expression Advanced Breast Cancer(GALAXY) Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05823623 Inetetamab Combined With Pyrotinib Plus Oral Vinorelbine for the Treatment of HER2-positive Metastatic Breast Cancer Status RECRUITING Phase PHASE2
NCT05823467 What is Optimal Post-operative Prophylactic Therapy in Irradiated Breasts Undergoing Repeat Surgery Status RECRUITING Phase NA
NCT05820373 The Effect of Yoga Therapy on Post-operative Side-effects Among Women With Breast Cancer Status COMPLETED Phase NA
NCT05817227 Selenoproteins as Prognostic Markers and Therapeutic Targets in Breast Cancer. Status RECRUITING Phase N/A
NCT05817175 International Prospective REgistry on Pre-pectorAl Breast REconstruction Status RECRUITING Phase N/A
NCT05816538 The Immune Response of Breast Cancer Patients Treated With Levobupivacaine Using Paravertebral or Superficial Chest Blocks Status ACTIVE_NOT_RECRUITING Phase NA
NCT05816187 Efficacy and Safety of Supervised Therapeutic Exercise in Cancer Patients With and Without Concurrent Treatment. Status COMPLETED Phase NA
NCT05814354 SHR-A1811 Versus Investigator's Chemotherapy in Recurrent/Metastatic Breast Cancer Clinical Trial Status RECRUITING Phase PHASE3
NCT05812924 A Novel Therapy for Breast Cancer Survivors With Genitourinary Syndrome of Menopause Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05810870 PIK3CA/PTEN-altered Advanced Breast Cancer Treated With MEN1611 Monotherapy or in Combination With Eribulin Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05810025 FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments Status COMPLETED Phase NA
NCT05808569 Evaluating Breast Cancer Patients Modesty During Radiotherapy. A Multicentric Study Status COMPLETED Phase N/A
NCT05807074 Impact of Topical Tranexamic Acid in Breast Reconstruction Status TERMINATED Phase PHASE4
NCT05806671 Dalpiciclib Plus Fulvestrant With Pyrotinib in Hormone Receptor-positive, HER2-low Advanced Breast Cancer That Progressed on Previous CDK4/6i Plus AI Therapy Status NOT_YET_RECRUITING Phase PHASE2
NCT05806138 A Study of Vericiguat in People With Breast Cancer and Cancer Therapy-Related Cardiac Dysfunction Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05804916 Optical Surface Monitoring Technology-Guided Large-Segment Radiotherapy for Breast Cancer Status RECRUITING Phase PHASE2/PHASE3